| Dr Vikki Ann Stefans, MD | |
|
1 Children's Way, Arkansas Children's Hospital, Little Rock, AR 72202-3500 | |
| (501) 364-4374 | |
| (501) 364-6829 |
| Full Name | Dr Vikki Ann Stefans |
|---|---|
| Gender | Female |
| Speciality | Pediatric Medicine |
| Experience | 45 Years |
| Location | 1 Children's Way, Little Rock, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841395423 | NPI | - | NPPES |
| 12047000000 | Other | AR | QUALCHOICE |
| 113043724 | Medicaid | AR | |
| 113696001 | Medicaid | AR | |
| N7236 | Other | AR | TRICARE |
| 51727 | Other | AR | BCBS |
| P8B063040 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081P0010X | Physical Medicine & Rehabilitation - Pediatric Rehabilitation Medicine | N7236 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uams Medical Center | Little rock, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Arkansas | 4082528955 | 1121 |
News Archive
AstraZeneca today announced new analyses of exenatide once weekly (ExQW) demonstrating a favorable gastrointestinal (GI) tolerability profile, including less frequent upper and lower GI adverse events (AE), compared to shorter-acting glucagon-like peptide-1 receptor agonists (GLP-1RA), exenatide twice daily (ExBID) and liraglutide once daily (LiraQD).
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the intestine that includes Crohn's disease and ulcerative colitis. A protective protein that plays a key role in this disease is "T-cell protein tyrosine phosphatase" or TCPTP.
Three years after an earthquake killed more than 200,000 people and left an estimated 1.5 million people homeless in Haiti, a Henry Ford Hospital study found that more mobilized medical care is necessary to bridge cultural and health care barriers and better serve the Haitian population.
A team of scientists from the Hebrew University of Jerusalem and the Weizmann Institute of Science has revealed the structure of a cellular editor that "cuts and pastes" the first draft of RNA straight after it is formed from its DNA template.
› Verified 5 days ago
| Entity Name | University Of Arkansas For Medical Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588654016 PECOS PAC ID: 4082528955 Enrollment ID: O20031219000706 |
News Archive
AstraZeneca today announced new analyses of exenatide once weekly (ExQW) demonstrating a favorable gastrointestinal (GI) tolerability profile, including less frequent upper and lower GI adverse events (AE), compared to shorter-acting glucagon-like peptide-1 receptor agonists (GLP-1RA), exenatide twice daily (ExBID) and liraglutide once daily (LiraQD).
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the intestine that includes Crohn's disease and ulcerative colitis. A protective protein that plays a key role in this disease is "T-cell protein tyrosine phosphatase" or TCPTP.
Three years after an earthquake killed more than 200,000 people and left an estimated 1.5 million people homeless in Haiti, a Henry Ford Hospital study found that more mobilized medical care is necessary to bridge cultural and health care barriers and better serve the Haitian population.
A team of scientists from the Hebrew University of Jerusalem and the Weizmann Institute of Science has revealed the structure of a cellular editor that "cuts and pastes" the first draft of RNA straight after it is formed from its DNA template.
› Verified 5 days ago
| Entity Name | University Of Arkansas For Medical Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346230968 PECOS PAC ID: 4082528955 Enrollment ID: O20040115000431 |
News Archive
AstraZeneca today announced new analyses of exenatide once weekly (ExQW) demonstrating a favorable gastrointestinal (GI) tolerability profile, including less frequent upper and lower GI adverse events (AE), compared to shorter-acting glucagon-like peptide-1 receptor agonists (GLP-1RA), exenatide twice daily (ExBID) and liraglutide once daily (LiraQD).
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the intestine that includes Crohn's disease and ulcerative colitis. A protective protein that plays a key role in this disease is "T-cell protein tyrosine phosphatase" or TCPTP.
Three years after an earthquake killed more than 200,000 people and left an estimated 1.5 million people homeless in Haiti, a Henry Ford Hospital study found that more mobilized medical care is necessary to bridge cultural and health care barriers and better serve the Haitian population.
A team of scientists from the Hebrew University of Jerusalem and the Weizmann Institute of Science has revealed the structure of a cellular editor that "cuts and pastes" the first draft of RNA straight after it is formed from its DNA template.
› Verified 5 days ago
| Entity Name | Arkansas Childrens Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598773079 PECOS PAC ID: 2769477744 Enrollment ID: O20040419000796 |
News Archive
AstraZeneca today announced new analyses of exenatide once weekly (ExQW) demonstrating a favorable gastrointestinal (GI) tolerability profile, including less frequent upper and lower GI adverse events (AE), compared to shorter-acting glucagon-like peptide-1 receptor agonists (GLP-1RA), exenatide twice daily (ExBID) and liraglutide once daily (LiraQD).
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the intestine that includes Crohn's disease and ulcerative colitis. A protective protein that plays a key role in this disease is "T-cell protein tyrosine phosphatase" or TCPTP.
Three years after an earthquake killed more than 200,000 people and left an estimated 1.5 million people homeless in Haiti, a Henry Ford Hospital study found that more mobilized medical care is necessary to bridge cultural and health care barriers and better serve the Haitian population.
A team of scientists from the Hebrew University of Jerusalem and the Weizmann Institute of Science has revealed the structure of a cellular editor that "cuts and pastes" the first draft of RNA straight after it is formed from its DNA template.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vikki Ann Stefans, MD 1 Children's Way, Arkansas Children's Hospital, Little Rock, AR 72202-3500 Ph: (501) 364-4374 | Dr Vikki Ann Stefans, MD 1 Children's Way, Arkansas Children's Hospital, Little Rock, AR 72202-3500 Ph: (501) 364-4374 |
News Archive
AstraZeneca today announced new analyses of exenatide once weekly (ExQW) demonstrating a favorable gastrointestinal (GI) tolerability profile, including less frequent upper and lower GI adverse events (AE), compared to shorter-acting glucagon-like peptide-1 receptor agonists (GLP-1RA), exenatide twice daily (ExBID) and liraglutide once daily (LiraQD).
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the intestine that includes Crohn's disease and ulcerative colitis. A protective protein that plays a key role in this disease is "T-cell protein tyrosine phosphatase" or TCPTP.
Three years after an earthquake killed more than 200,000 people and left an estimated 1.5 million people homeless in Haiti, a Henry Ford Hospital study found that more mobilized medical care is necessary to bridge cultural and health care barriers and better serve the Haitian population.
A team of scientists from the Hebrew University of Jerusalem and the Weizmann Institute of Science has revealed the structure of a cellular editor that "cuts and pastes" the first draft of RNA straight after it is formed from its DNA template.
› Verified 5 days ago
Mike C Umerah, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 500 S University Ave, Suite 705, Little Rock, AR 72205 Phone: 501-664-2991 Fax: 501-664-7111 | |
Dr. Regina Kay Pondexter Hunter, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 500 S University Ave Ste 318, Little Rock, AR 72205 Phone: 501-225-6900 Fax: 501-225-6911 | |
Dr. David C Culver, DO Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4300 W 7th St, Little Rock, AR 72205 Phone: 501-257-1000 Fax: 501-257-6419 | |
Stephen Paulus, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 800 Fair Park Blvd, Little Rock, AR 72204 Phone: 501-604-6900 Fax: 501-604-6941 | |
Esther Tompkins, DO Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1 Childrens Way # 653, Little Rock, AR 72202 Phone: 501-364-1100 Fax: 501-364-4082 | |
Dr. Leigh Henderson, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 9501 Baptist Health Dr Fl 1, Little Rock, AR 72205 Phone: 501-202-7395 Fax: 501-202-7333 | |
Mark Reed, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 |